Showing results (231-240 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|October 17, 2022
MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case reportWonyoung Choi, Kyung-Chae Jeong, Seog-Yun Park, et al.
Translational Lung Cancer Research|September 12, 2022
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodesBolun Zhou, Ruochuan Zang, Moyan Zhang, et al.
Translational Lung Cancer Research|September 12, 2022
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumabYinchen Shen, Jiaqi Li, Huiping Qiang, et al.
Translational Lung Cancer Research|January 24, 2022
Risk-based prediction model for selecting eligible population for lung cancer screening among ever smokers in KoreaBoyoung Park, Yeol Kim, Jaeho Lee, et al.
Translational Lung Cancer Research|January 24, 2022
Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinomaGuochao Zhang, Xuefei Wang, Jia Jia, et al.
Translational Lung Cancer Research|January 24, 2022
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatmentsYuequan Shi, Xiaoyan Liu, Jia Liu, et al.
Translational Lung Cancer Research|January 24, 2022
Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancerChangjian Shao, Kai Guo, Liqun Xu, et al.
Translational Lung Cancer Research|January 24, 2022
Airway management and anesthesia for airway surgery: a narrative reviewLucy T Li, Hovig V Chitilian, Paul H Alfille, et al.
Translational Lung Cancer Research|January 24, 2022
Use of adjuvant chemotherapy in resected non-small cell lung cancer in real-life practice: a systematic review of literatureAnne-Laure Desage, Wafa Bouleftour, Olivier Tiffet, et al.
Translational Lung Cancer Research|September 29, 2021
Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer: a prospective observational studyAkihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma, et al.
Pageof 240